hids
Showing 1 - 8 of 8
Systemic Juvenile Idiopathic Arthritis, Hereditary Periodic Fevers Trial in Bron Cedex, Le Kremlin Bicetre, Paris (canakinumab)
Completed
- Systemic Juvenile Idiopathic Arthritis
- Hereditary Periodic Fevers
-
Bron Cedex, France
- +2 more
May 7, 2020
B7 Coreceptor Molecules in Hyper IgD Syndrome Form of Mevalonate
Withdrawn
- Hyper IgD Syndrome
- Mevalonate Kinase Deficiency
-
Houghton, Michigan
- +3 more
Jun 14, 2018
Periodic Fevers Syndrome Trial in Fukuoka city, Yokohama-city, Kyoto-city (Canakinumab (AIN457))
Completed
- Periodic Fevers Syndrome
- Canakinumab (AIN457)
-
Fukuoka city, Fukuoka, Japan
- +2 more
Nov 30, 2017
Mucopolysaccharidosis II, MPS II Trial in United States (SB-913)
Terminated
- Mucopolysaccharidosis II
- MPS II
- SB-913
-
Oakland, California
- +4 more
Oct 21, 2022
Dietary Cholesterol and Defects in Cholesterol Synthesis in
Terminated
- Mevalonic Aciduria
- +4 more
-
Portland, OregonOregon Health & Science University
May 22, 2019
Hereditary Periodic Fevers Trial in Worldwide (Canakinumab, Placebo)
Completed
- Hereditary Periodic Fevers
- Canakinumab
- Placebo
-
Los Angeles, California
- +64 more
Apr 6, 2018
Mevalonate Kinase Deficiency Trial in Esplugues de Llobregat, Valencia, Madrid (Canakinumab)
Completed
- Mevalonate Kinase Deficiency
-
Esplugues de Llobregat, Barcelona, Spain
- +2 more
Oct 13, 2015
Autoinflammatory Syndromes, HIDS, TRAPS Trial in Nijmegen (ITF2357)
Unknown status
- Autoinflammatory Syndromes
- +3 more
-
Nijmegen, NetherlandsRadboud University Medical Centre Nijmegen
Feb 28, 2007